Kapiva is an Ayurvedic nutrition brand that secured Rs 83.5 crore in its ongoing funding round. This round was led by OrbiMed Asia and had the participation of other investors including 3one4 Capital. OrbiMed Asia led the round with Rs 52.2 crore followed by Vertex Ventures with 19.33 crore and the rest of the Rs 11.96 crore came from 3one4 Capital. This funding round is expected to be a part of Kapiva’s Rs 250 crore series C funding round.
The startup plans to use this fresh capital to scale operations, expand its network, introduce new products, and enhance its platform. The board has approved a resolution to allot 5,62,631 compulsory convertible preference shares to raise $10 million. According to the company filing, the startup will use these fresh proceeds for development and market expansion. The startup offers various healthcare products including ayurvedic teas, nutrition powder, and medicines. The company also provides doctor’s guidance on health concerns like weight management, skin care, daily wellness, and hair care.
The tracxn data shows that the startup has raised around $41.1 million across nine funding rounds since its inception, including a $107k round from angel investors. The startup also increased its ESOP pool size by adding 1,415,00 new employee stock to its existing stock plan pool of 4,47,741 worth Rs 66 crore. After this round, the existing investor OrbiMed Asia remains the largest external stakeholder of the firm.
Kapiva posted an 87 percent YoY increase in its financial growth to Rs 116.48 crore in FY23. However, the net loss stood out at Rs 64.5 crore in the same duration. The company intends to use some of this fund to strengthen its platform and expand its services in India. The brand offers clinically tested and expert-formulated nutritional products. The startup data intelligence platform, thekredible mentioned the company’s post-allotment valuation to be around 80 million USD. The firm may use a portion of this investment to grow its brand presence.
Kapiva offers a platform that provides natural and organic health, hair fall, weight loss, or digestion products. The company operates in omnichannel mode and aims to establish more physical stores. The startup faces competition from other ayurvedic healthcare product offering platforms such as LifeVantage, Metagenics, and Labomar. This investment shows investor’s trust in Kapiva’s market potential and business model.
Conclusion :
Kapiva is a Bengaluru-based D2C startup that provides Ayurvedic healthcare products. The startup secured fresh capital of $10 million from OrbiMed Asia in its fresh funding round. The funding round had participation from other investors, including 3one4 Capital, Vertex Ventures, and others. The company plans to use this amount to scale its operations, introduce more categories, expand to services, and develop its brand presence.
OrbiMed Asia led the round with Rs 52.2 crore followed by Vertex ventures with Rs 19.33 crore while 3One4 Capital invested Rs 11.96 crore. After this round, the existing investor OrbiMed Asia remains the firm’s largest external stakeholder. The company’s board approved the resolution to allot 5,62,631 CCPS to raise Rs 83.5 crore.
0 Comments